ASC final rule: Fee increases for ophthalmology ASCs

Subscribe or sign in to view the full article.

Note:  The following article synopsis was NOT provided by HCPro. It was created by Find-A-Code/innoviHealth.

Article Overview

This article explains how CMS’s final ASC payment rule affects ophthalmology ASCs, including broader coverage of procedures, phased payment updates, and policy issues tied to facility reimbursement. It is aimed at ophthalmologists, ASC owners, and coding/billing professionals who need to understand which ophthalmic services are affected and how the rule changes the ASC payment landscape. The discussion also covers selected operational concerns, device-related payment changes, and differences between ASC and other outpatient payment settings.

Why This Topic Matters

The rule changes which ophthalmic procedures can be performed in ASCs and how those services are paid over time, making it important for Medicare billing, ASC financial planning, and service-line decisions.

Article Sections

  1. ASC fee schedule and payment system overview

    Introduces the CMS final ASC fee schedule and the broader payment system changes affecting ophthalmology ASCs. Summarizes the overall scope of the rule and its timing.

  2. Impact on ophthalmology procedures and payment trends

    Reviews the expansion of ASC-payable ophthalmic services and the general direction of fee changes over the transition period. Includes broad discussion of how ophthalmology is affected relative to other specialties.

  3. Commonly performed ophthalmology procedures: ASC fees for 2008-2011

    Presents a table of selected ophthalmology procedures and their ASC payment amounts across multiple years. Focuses on payment comparisons and changes over time.

  4. Concerns with the final rule

    Discusses policy concerns raised by industry stakeholders, including stay-duration rules, unlisted procedures, and the treatment of devices and implants. Also notes the effect on certain ophthalmic services and related payment issues.

  5. Drugs and biologics

    Summarizes how the rule addresses drugs, biologics, and related tissue acquisition costs in ASCs. Compares the ASC approach with hospital outpatient payment policy.

What You Will Learn

  • How the CMS final ASC rule affects ophthalmology ambulatory surgery centers
  • Which broad categories of ophthalmic services were added to ASC payment coverage
  • How ASC payment changes phase in over time
  • What operational and reimbursement concerns were raised about the final rule
  • How the rule addresses devices, implants, drugs, biologics, and tissue-related costs

Who Should Read This

  • Ophthalmologists
  • ASC administrators
  • Medical coders
  • Billing staff
  • Revenue cycle professionals
  • Practice managers

Codes Discussed


Subscribe or sign in to view the full article.

Official DecisionHealth® Newsletter Archives includes:

  • Includes over 25,000 articles from:
    • Coder Pink Sheets
    • Part B News
    • Answer Books newsletters
  • Current newsletters added each quarter
  • Timely news and guidance vital for your practice
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to the Find-A-Code Code Information pages
  • Code Information pages link back to related articles
  • Save yourself tons of research time, find everything in one place!
Access to this feature is available in the following products:
  • DecisionHealth Coding, Billing and Compliance Library

Related Articles

Articles are listed in order of calculated relevance.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?